Yahoo · Oct 15, 2026
Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?
PBH's brand-building, acquisitions and e-commerce growth support fiscal 2027 revenue gains, but competition and currency risks remain key challenges.
NYSE · PBH
Prestige Consumer Healthcare Inc.
Healthcare · Medical - Distribution
$49.06
Up+$0.31 (+0.64%)
Updated Nov 2, 2026, 11:00 AM
SID Score
6.1/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 3.01B
- P/E ratio
- 14.86
- Dividend yield
- 0.00%
- 52-week range
- $42.62 – $67.00
- Volume
- 371.49K
- Avg. volume
- 457.59K
Price performance · PBH
PBH price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
PBH closed at $49.06 after 20 trading sessions, up 7.59% for the selected period.
- Last close
- $49.06
- Period change
- +7.59%
- Period low
- $45.60
- Period high
- $49.92
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $50.23 | $50.23 | $48.78 | $49.06 | 371.49K |
| Oct 29, 2026 | $48.71 | $48.97 | $47.88 | $48.75 | 343.41K |
| Oct 28, 2026 | $46.84 | $48.13 | $46.63 | $47.79 | 504.89K |
| Oct 27, 2026 | $47.79 | $47.79 | $46.4725 | $47.39 | 576.29K |
| Oct 26, 2026 | $48.00 | $48.7775 | $47.71 | $48.15 | 588.24K |
| Oct 23, 2026 | $48.96 | $49.3427 | $47.70 | $47.80 | 529.77K |
| Oct 22, 2026 | $48.49 | $49.635 | $47.50 | $49.46 | 660.9K |
| Oct 21, 2026 | $48.77 | $48.84 | $47.495 | $47.92 | 424.3K |
| Oct 20, 2026 | $50.35 | $50.37 | $48.99 | $49.36 | 536.73K |
| Oct 19, 2026 | $49.68 | $50.5899 | $49.41 | $49.71 | 682.14K |
| Oct 16, 2026 | $49.48 | $50.27 | $49.2815 | $49.92 | 580.66K |
| Oct 15, 2026 | $49.41 | $50.84 | $48.83 | $49.20 | 533.93K |
| Oct 14, 2026 | $48.70 | $49.15 | $47.85 | $48.40 | 683.97K |
| Oct 13, 2026 | $49.52 | $49.78 | $48.45 | $48.50 | 494.72K |
| Oct 12, 2026 | $48.52 | $49.41 | $47.80 | $49.00 | 416.36K |
| Oct 9, 2026 | $47.80 | $48.73 | $47.48 | $48.23 | 323.71K |
| Oct 8, 2026 | $47.62 | $47.94 | $46.74 | $47.87 | 558.51K |
| Oct 7, 2026 | $46.57 | $47.72 | $46.34 | $47.57 | 460.85K |
| Oct 6, 2026 | $45.90 | $46.61 | $45.58 | $46.44 | 660.93K |
| Oct 5, 2026 | $45.11 | $45.875 | $44.77 | $45.60 | 604.39K |
Latest PBH news
The latest Smart Investors Daily articles mentioning PBH.
Stock researchCompany · Overview
Company
Market Activity
Research & News
PBH research
Overview
Company profile and research snapshot.
Company profile
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $71.00
- Implied upside
- —
- Analysts
- 10
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 15, 2026 | Canaccord Genuity | Buy | — |
| May 14, 2026 | Oppenheimer | Perform | — |
| May 7, 2026 | Oppenheimer | Outperform | — |
| Feb 2, 2026 | Jefferies | Hold | — |
| Nov 7, 2025 | Canaccord Genuity | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 14, 2026
Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results
TARRYTOWN, N.Y., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2027 second quarter and first half earnings release on Thursday, November 5, 2026 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerh
Benzinga · Oct 7, 2026
Transcript: Prestige Consumer Q1 2027 Earnings Conference Call
Prestige Consumer (NYSE:PBH) reported first-quarter financial results on Thursday. The transcript from the company's first-quarter earnings call has been provided below. This transcript is brought to you by Benzinga
Yahoo · Oct 1, 2026
Best Value Stocks to Buy for October 1st
BP and PBH made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 1, 2026.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
